Director · PTC THERAPEUTICS, INC. · PTC THERAPEUTICS, INC. — Stock Option (Right to Buy)
Side
M
Value
—
Shares
10.0K
Price
—
Executed
Nov 21, 2025
Disclosed
Nov 25, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 21 executedNov 25, 2025 disclosed
PTCT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
PTC THERAPEUTICS, INC. — Stock Option (Right to Buy)
Ticker
PTCT
Shares
10.0K
Price per share
$0
Execution date (reported)
Nov 21, 2025
Owned after transaction
0 shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
4
What this establishes
Reeve Emma filed this Form 4 reporting a option exercise of PTCT on Nov 21, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Reeve Emmacik:0001680329
Issuer
PTC THERAPEUTICS, INC.cik:0001070081
Revision history · 0
No field has changed since this record was first ingested.
